You just read:

Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis

News provided by

Novartis Pharmaceuticals Corporation

Sep 16, 2011, 11:45 ET